1 of 1
Story summary
- REMSleep Holdings, Inc. will shift from infrastructure development to market execution in Q1 2026 to generate cash flow.
- CEO Thomas Wood targets 1,500 to 1,600 CPAP masks per month as a sustainable benchmark.
- REMSleep submitted a supplemental 510(k) submission to the FDA to expand DeltaWave's use to clinical settings.
- The company plans backup options for CPAP patients, online-retailer partnerships, and institutional sales, pending FDA approval.
